课题基金 / 基金详情

ANTIGEN PRESENTATION FUNCTION OF HUMAN CD1D

ANTIGEN PRESENTATION FUNCTION OF HUMAN CD1D
人CD1D的抗原呈递功能
批准号:
2460908
负责人:
JULI K MAHER
金额:
$8.69万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 2000-04-30

项目摘要

项目成果

JULI K MAHER的其他基金

相似基金

相关文献

中文摘要
翻译
拟议项目的目标是:1)培训申请者进行 独立的、新颖的、生物医学研究,在兽医学院任教 和2)研究分子间的相互作用 非多态MHC-I类人CDLD分子及其潜能 配基。这一奖项将允许申请者使用她的分子生物学 在赞助商的密集调研期间的体会 实验室,申请者在那里利用她的分子生物学经验 在赞助商实验室的密集研究期间, 申请者将获得相关蛋白质领域的经验 生物化学和细胞免疫学,同时继续她在 免疫学。尽管有报道描述了细胞介导的免疫反应 仅限于人CD1a、-b和-c分子和小鼠CD1,不清楚 有证据表明,人类CD-LD参与了免疫反应。 这项拟议的研究旨在确定人类CDLD分子是否可以 在抗原提呈能力中的作用,以及它们在 豁免权。具体地说,候选人将与克伦伯格博士合作 确定与人CDLD相关的配体类型(S)及其相互作用 结合的亲和力。我们建议确定人类CDLD是否可以结合 脂类或糖脂,类似于人类的其他分子成员 CD1家族或多肽,以及它的小鼠同源物。生物学的 人类CD1d配体结合的相关性将通过推导 人外周血中CDLD/抗原特异性T细胞,类似于 在赞助商实验室的小鼠身上进行的研究。 具体地说,我们建议检测CDLD抵抗的T细胞是否 自身反应性,据报道,在T细胞中的一个保守的亚群 小鼠或如果细胞介导的免疫反应需要人CD1d相关 里根。此外,申请者将确定是否与人的Ligan结合 CDLD或T细胞识别需要具有CDLD重量级的b2-微球蛋白 链条。人类CDLD特异性表达结构的发展, 转化的细胞系和纯化的蛋白将有助于这些研究。
英文摘要
The goals of the proposed project are 1) to train the applicant to conduct independent, novel, biomedical research as academic faculty at a vetinary or mdecal school and 2) to investigate molecular interactions between the non-polymorphic MHC class I-like human CDld molecules and potential ligands. This award will allow the applicant to use her molecular biology experience during an intensitive period of research in the sponsor's laboratory, in which the applicant to use her molecular biology experience during an intensive period of research in the sponsor's laboratory, in which the applicant will gain experience in the related fields of protein biochemistry and cellular immunology while continuing her education in immunology. Despite reports describing cell-mediated immune responses restricted to human CD1a, -b, and -c molecules and mouse CD1, no clear evidence of human CD ld involvement in immune responses has been reported. The proposed research is designed to determine if human CDld molecules can function in an antigen presenting capacity, and their possible role in immunity. Specifically, the candidate will work with Dr. Kroneberg to determine the types of ligand(s) that associate with human CDld and their affinities of binding. We propose to determine whether human CDld can bind lipids or glycolipids, similar to the other molecule members of the human CD1 family, or peptides, as does its murine homologue. The biological relevance of human CD1d ligand binding will be addressed by deriving CDld/antigen specific T cells from human peripheral blood, similar to studies performed in the mouse in the laboratory of the sponsor. Specifically, we propose to detemrine if CDld-restircted T cell are autoreactive, as has been reported for a conserved subset of T cells in the mouse or if cell-mediated immune responses require a human CD1d-associated ligan. In addition, the applicant will determine if ligan-binding to human CDld or T cell recognition requires b2-microglobulin with the CDld heavy chain. The development of human CDld-specific expression constructs, transfected cell lines, and purified protein will facilitate these studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE ROLE OF MHC CLASS II GENES IN LUPUS
THE ROLE OF MHC CLASS II GENES IN LUPUS
CONTROL OF EXPRESSION OF MHC GENES IN PLACENTA
  • 批准号:
    2195653
  • 项目类别:
  • 资助金额:
    $1.63万
  • 财政年份:
    1993
  • 负责人:
    JULI K MAHER
  • 依托单位:
CONTROL OF EXPRESSION OF MHC GENES IN PLACENTA
  • 批准号:
    3049027
  • 项目类别:
  • 资助金额:
    $3.12万
  • 财政年份:
    1992
  • 负责人:
    JULI K MAHER
  • 依托单位:
海外基金